Isotechnika Pharma Inc IPHAF

RE: 101 drop outs

[labumba]

you guys are unbelievable..you do you mean " the drug is inended for use for only 6 months in psoriasis " ????? Are you talking about the trial ??....the trial is 6 month duration which is correct. The extension is another 6 month which all patients can take part voluntarily. The data just released includes 24 week of the trial including 193 patients who have extended their treatment up to present as in total 48 weeks. In the webcast they were talking about 48 week data as it was more or less the same as 24 weeks and they used 24 data " charts ", which is only available at present to back up the QA session as 24 extension trial data were still preliminary. Man man man, you guys are really twisting things around ! The following is from the news release today, read with your eye wide open: " To date, data has been received on 193 patients receiving treatment for a total of 48 weeks. Patients previously in the low dose group experienced an improvement in mean percent decrease in PASI scores from baseline of 41% to 64% after an additional 24 weeks on the mid dose. Patients previously in the mid and high dose group remained stable with mean percent decrease from baseline PASI scores of 61% and 66%, respectively after a total of 48 weeks of treatment. "